-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Nascent Biotech Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2015 to 2017.
- Nascent Biotech Inc. Earnings Per Share, Diluted for the quarter ending December 31, 2022 was -0.01 USD/shares, a 200% decline year-over-year.
- Nascent Biotech Inc. annual Earnings Per Share, Diluted for 2017 was -0.09 USD/shares, a 280% decline from 2016.
- Nascent Biotech Inc. annual Earnings Per Share, Diluted for 2016 was 0.05 USD/shares.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)